Analyzing the symptoms in cancer patients

IEEE Engineering in Medicine and Biology Magazine

Volumn 27, Issue 1, 2008, Pages 25-28

  Rich, Tyvin A ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; TRANSFORMING GROWTH FACTOR ALPHA;

ANOREXIA; APOPTOSIS; AROUSAL; ARTICLE; BRAIN STEM; CANCER PATIENT; CIRCADIAN RHYTHM; COLORECTAL CANCER; CORE TEMPERATURE; FATIGUE; FOREBRAIN; HUMAN; HYPOTHALAMUS; NERVE CELL; QUESTIONNAIRE; SIGNAL TRANSDUCTION; SLEEP; SLEEP DEPRIVATION; SUPRACHIASMATIC NUCLEUS;

CIRCADIAN RHYTHM; HUMANS; HYPOTHALAMUS; MODELS, NEUROLOGICAL; NEOPLASMS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION;

EID: 38549150262     PISSN: 07395175     EISSN: None     Source Type: Journal    
DOI: 10.1109/MEMB.2007.907364     Document Type: Article

References (12)

1. M. H. Hastings and E. D. Herzog, "Clock genes, oscillators, and cellular networks in the suprachiasmatic nuclei," J. Biol. Rhythms, vol. 19, no. 5, pp. 400-413, 2004.
2. A. Kramer, F. C. Yang, P. Snodgrass, X. Li, T. E. Scammell, F. C. Davis, and C. J. Weitz, "Regulation of daily locomotor activity and sleep by hypothalamic EGF receptor signaling," Science, vol. 294, no. 5551, pp. 2511-2515, 2001.
3. A. Kramer, F. C. Yang, S. Kraves, and C. J. Weitz, "A screen for secreted factors of the suprachiasmatic nucleus," Meth. Enzymol., vol. 393, no. 1, pp. 645-663, 2005.
4. P. Snodgrass-Belt, J. L. Gilbert, and F. C. Davis, "Central administration of transforming growth factor-alpha and neuregulin-1 suppress active behaviors and cause weight loss in hamsters," Brain Res., vol. 1038, no. 2, pp. 171-182, 2005.
5. C. B. Saper, J. Lu, T. C. Chou, and J. Gooley, "The hypothalamic integrator for circadian rhythms," Trends Neurosci., vol. 28, no. 3, pp. 152-157, 2005.
6. J. Lu, Y. H. Zhang, T. C. Chou, S. E. Gaus, J. K. Elmquist, P. Shiromani, and C. B. Saper, "Contrasting effects of ibotenate lesions of the paraventricular nucleus and subparaventricular zone on sleep-wake cycle and temperature regulation," J. Neurosci., vol. 21, no. 13, pp. 4864-4874, 2001.
7. C. B. Saper, T. E. Scammell, and J. Lu, "Hypothalamic regulation of sleep and circadian rhythms," Nature, vol. 437, no. 7063, pp. 1257-1263, 2005.
8. C. Von Economo, "Sleep as a problem of localization," J. Nerv. Ment. Dis., vol. 71, pp. 249-259, 1930.
9. C. Arteaga, "Targeting HER1/EGFR: A molecular approach to cancer therapy," Semin. Oncol., vol. 30, Suppl. 7, pp. 3-14, 2003.
10. C. S. Cleeland, T. R. Mendoza, X. S. Wang, C. Chou, M. T. Harle, M. Morrissey, and M. C. Engstrom, "Assessing symptom distress in cancer patients: The M.D. Anderson Symptom Inventory," Cancer, vol. 89, no. 7, pp. 1634-1646, 2000.
11. C. S. Cleeland, G. J. Bennett, R. Dantzer, P. M. Dougherty, A. J. Dunn, C. A. Meyers, A. H. Miller, R. Payne, J. M. Reuben, X. S. Wang, and B. N. Lee, "Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms," Cancer, vol. 97, no. 11, pp. 2919-2925, 2003.
12. T. Rich, P. F. Innominato, J. Boerner, M. C. Mormont, S. Iacobelli, B. Baron, C. Jasmin, and F. Levi, "Elevated serum cytokines correlated with altered behavior, serum cortisol rhythm, and dampened 24-hour rest-activity patterns in patients with metastatic colorectal cancer," Clin. Cancer Res., vol. 11, no. 5, pp. 1757-1764, 2005.